相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Prognostic value of receptor status conversion following neoadjuvant chemotherapy in breast cancer patients: a systematic review and meta-analysis
Chao Li et al.
BREAST CANCER RESEARCH AND TREATMENT (2019)
Re-testing of predictive biomarkers on surgical breast cancer specimens is clinically relevant
Stephanie Robertson et al.
BREAST CANCER RESEARCH AND TREATMENT (2019)
Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update
Antonio C. Wolff et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Effects of core needle biopsy and subsequent neoadjuvant chemotherapy on molecular alterations and outcome in breast cancer
Lingmin Xie et al.
ONCOTARGETS AND THERAPY (2018)
Establishment and external validation of a prognostic model for predicting disease-free survival and risk stratification in breast cancer patients treated with neoadjuvant chemotherapy
Jianguo Lai et al.
CANCER MANAGEMENT AND RESEARCH (2018)
Changes in tumor expression of HER2 and hormone receptors status after neoadjuvant chemotherapy in 21 755 patients from the Japanese breast cancer registry
N. Niikura et al.
ANNALS OF ONCOLOGY (2016)
Impact of biomarker changes during neoadjuvant chemotherapy for clinical response in patients with residual breast cancers
Yukie Enomoto et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2016)
Impact of Molecular Subtype Conversion of Breast Cancers after Neoadjuvant Chemotherapy on Clinical Outcome
Siew Kuan Lim et al.
CANCER RESEARCH AND TREATMENT (2016)
Receptor Status Change From Primary to Residual Breast Cancer After Neoadjuvant Chemotherapy and Analysis of Survival Outcomes
Napa Parinyanitikul et al.
CLINICAL BREAST CANCER (2015)
Reproducibility of residual cancer burden for prognostic assessment of breast cancer after neoadjuvant chemotherapy
Florentia Peintinger et al.
MODERN PATHOLOGY (2015)
Prognostic value of receptor conversion after neoadjuvant chemotherapy in breast cancer patients: a prospective observational study
Xi Jin et al.
ONCOTARGET (2015)
Tumor Response Ratio Predicts Overall Survival in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy
Marian Miller et al.
ANNALS OF SURGICAL ONCOLOGY (2014)
Modulatory effect of neoadjuvant chemotherapy on biomarkers expression; assessment by digital image analysis and relationship to residual cancer burden in patients with invasive breast cancer
Amber Cockburn et al.
HUMAN PATHOLOGY (2014)
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
Patricia Cortazar et al.
LANCET (2014)
Correlation between response to neoadjuvant chemotherapy and survival in locally advanced breast cancer patients
A. Romero et al.
ANNALS OF ONCOLOGY (2013)
Accuracy of estrogen receptor, progesterone receptor, and HER2 status between core needle and open excision biopsy in breast cancer: a meta-analysis
Xiaosong Chen et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Definition and Impact of Pathologic Complete Response on Prognosis After Neoadjuvant Chemotherapy in Various Intrinsic Breast Cancer Subtypes
Gunter von Minckwitz et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Pathologic Complete Response Predicts Recurrence-Free Survival More Effectively by Cancer Subset: Results From the I-SPY 1 TRIAL-CALGB 150007/150012, ACRIN 6657
Laura J. Esserman et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer
M. Elizabeth H. Hammond et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Change in the hormone receptor status following administration of neoadjuvant chemotherapy and its impact on the long-term outcome in patients with primary breast cancer
T. Hirata et al.
BRITISH JOURNAL OF CANCER (2009)
Loss of HER2 Amplification Following Trastuzumab-Based Neoadjuvant Systemic Therapy and Survival Outcomes
Elizabeth A. Mittendorf et al.
CLINICAL CANCER RESEARCH (2009)
Recent advances in systemic therapy Advances in neoadjuvant (primary) systemic therapy with cytotoxic agents
Michael Untch et al.
BREAST CANCER RESEARCH (2009)
Changes in and prognostic value of hormone receptor status in a series of operable breast cancer patients treated with neoadjuvant chemotherapy
Olivier Tacca et al.
ONCOLOGIST (2007)
A stepwise AIC method for variable selection in linear regression
Toshie Yamashita et al.
COMMUNICATIONS IN STATISTICS-THEORY AND METHODS (2007)
Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: An update
M Kaufmann et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
High prognostic significance of residual disease after neoadjuvant chemotherapy:: a retrospective study in 710 patients with operable breast cancer
S Amat et al.
BREAST CANCER RESEARCH AND TREATMENT (2005)
分享论文
